Mahmoud Diab, MD, M.Sc.

Radiology Research Fellow, M.D. Anderson Cancer Center #Radiologist

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

Excited to share our recent @RadioGraphics manuscript on Cowden syndrome, covering its diverse imaging manifestations, genetic background, and cancer surveillance considerations

[RadioGraphics @RadioGraphics]

From trichilemmomas to Lhermitte-Duclos disease, Cowden syndrome has diverse imaging manifestations. This review outlines the genetics, key radiologic findings, and cancer surveillance strategies for this PTEN-related disorder. @MindyWangMD @ElsayesKhaled https://t.co/5NzLcTksK0

[Abdominal Radiology @Abdominal_Rad]

Editor-in-Chief’s Highlights – March 2026 Issue

Assessment prior to liver tumor resection: what a radiologist needs to know
Wang et al

https://t.co/hVOsXeEWtT

#abdrad #radres #radiology #FOAMrad

@RadGeek
@LetDdiceFlyHigh
@ClinMedJournals
@SocietyAbdRad

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

Check out our latest published article in @RadioGraphics on the imaging spectrum and diagnostic insights of mastocytosis.

[RadioGraphics @RadioGraphics]

Due to overlapping features with other clonal hematologic disorders, understanding the pathogenesis, classification, and imaging features of mastocytosis is essential for diagnosis and effective disease monitoring. https://t.co/Bk0y0qaMSg

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

@mayumi_0130 @mobakrmd The goal is to refine surveillance, reduce unnecessary radiation and patient anxiety, and focus resources where they can have the greatest impact, without compromising survival or overall patient outcomes.

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

In patients with intrahepatic cholangiocarcinoma, the value of routine chest CT after resection remains debated.
Our study with @mobakrmd in J Gastrointest Oncol addresses this important clinical question:
🔗 https://t.co/BERylGzY1i
#Radiology #Oncology #Cholangiocarcinoma

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

@mayumi_0130 @mobakrmd Even those with isolated thoracic disease later developed metastases at other sites, with varying intervals. The next step is to study this subgroup to assess potential predictors (MVI, TNM…etc) to see if routine chest CT follow-up should be limited to high-risk patients.

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

Highlighting one of my earlier works on renal cell carcinoma. The review discusses how tumor genetics and molecular biology shape imaging, diagnosis, and management.

Read here 👉 https://t.co/I5X2L2mBBL

#Oncology #Radiology #RCC

[Mahmoud Diab, MD, M.Sc. @Diab_MahmoudS]

📢 New article out!
“Hereditary Renal Cell Carcinoma: An Imaging Update”
with @MindyWangMD @ElsayesKhaled

Key insights on genetics, imaging features, and NCCN guideline updates for screening & management.

Read here 👉 https://t.co/BlzTPG9k71

#Radiology #Oncology #RCC #NCCN